The ETS domain transcription factor ELK1 directs a critical component of growth signaling by the androgen receptor in prostate cancer cells
about
LncRNA-TCONS_00026907 is involved in the progression and prognosis of cervical cancer through inhibiting miR-143-5pTranscriptome analysis of the dihydrotestosterone-exposed fetal rat gubernaculum identifies common androgen and insulin-like 3 targetsSex bias in CNS autoimmune disease mediated by androgen control of autoimmune regulator.Androgenic regulation of beta-defensins in the mouse epididymis.Cyr61 promotes epithelial-mesenchymal transition and tumor metastasis of osteosarcoma by Raf-1/MEK/ERK/Elk-1/TWIST-1 signaling pathway.The ETS family of oncogenic transcription factors in solid tumours.Differential effects of estrogen-dependent transactivation vs. transrepression by the estrogen receptor on invasiveness of HER2 overexpressing breast cancer cells.Osteopontin-c mediates the upregulation of androgen responsive genes in LNCaP cells through PI3K/Akt and androgen receptor signaling.Pin1 Inhibitor Juglone Exerts Anti-Oncogenic Effects on LNCaP and DU145 Cells despite the Patterns of Gene Regulation by Pin1 Differing between These Cell Lines.Silodosin inhibits the growth of bladder cancer cells and enhances the cytotoxic activity of cisplatin via ELK1 inactivation.ELK1 is up-regulated by androgen in bladder cancer cells and promotes tumor progressionA Signaling Network Controlling Androgenic Repression of c-Fos Protein in Prostate Adenocarcinoma Cells.The Amino-terminal Domain of the Androgen Receptor Co-opts Extracellular Signal-regulated Kinase (ERK) Docking Sites in ELK1 Protein to Induce Sustained Gene Activation That Supports Prostate Cancer Cell Growth.Hybrid Enzalutamide Derivatives with Histone Deacetylase Inhibitor Activity Decrease Heat Shock Protein 90 and Androgen Receptor Levels and Inhibit Viability in Enzalutamide-Resistant C4-2 Prostate Cancer CellsSilodosin inhibits prostate cancer cell growth via ELK1 inactivation and enhances the cytotoxic activity of gemcitabine.DNA-PKcs-Mediated Transcriptional Regulation Drives Prostate Cancer Progression and Metastasis.PRK1/PKN1 controls migration and metastasis of androgen-independent prostate cancer cells.NDUFA4L2 is associated with clear cell renal cell carcinoma malignancy and is regulated by ELK1.Regulatory activity based risk model identifies survival of stage II and III colorectal carcinoma.Histone deacetylase 6 (HDAC6) deacetylates extracellular signal-regulated kinase 1 (ERK1) and thereby stimulates ERK1 activity.Divergence in DNA Specificity among Paralogous Transcription Factors Contributes to Their Differential In Vivo Binding.Expression of Phospho-ELK1 and Its Prognostic Significance in Urothelial Carcinoma of the Upper Urinary Tract.AIRE promotes androgen-independent prostate cancer by directly regulating IL-6 and modulating tumor microenvironment.
P2860
Q33775216-A3DBDB5F-7A72-4AFD-B808-C7C0AE0A2955Q33826110-BF60C117-45DB-4372-B3F5-4A4A6BFF9448Q33908337-0EAB8038-F10C-4197-B0C9-3BDAB80D408CQ34023380-778DDAC5-2AA1-4230-A385-87C7872D7F79Q34410089-6AAEE393-B9A1-44B2-A114-F217A91BA4F4Q34555986-06056AEB-BA4E-46CD-8D30-F985F903E9DDQ35101137-A65185C0-9B49-4115-B226-0EEE2FC4C6D1Q35167752-7E67A9BA-0A64-472B-B02A-BEEA16862B58Q35650902-EA51B8E1-25F7-477A-B891-D32CB81AA11EQ36309363-F364305C-D9D6-4688-8CB4-A0B70037A6A0Q36557452-F06F3180-4640-453B-9FBF-D329A8902792Q36674584-9AB296A2-7398-4E69-8D2E-6FBCF1B2AC51Q37551286-13F48C82-D65A-4F4C-A011-0D205D75D494Q38759678-EDD21D88-56F1-439B-BFC0-D5521740F2A8Q38795167-5F80D823-5CE7-4BF9-A857-76F56B72F9B1Q38852980-867854CB-AC18-4D15-9178-8C3652A6585BQ38928703-F10F2C5E-50A4-4C54-A1EF-78CF19AAA1E1Q47134100-68B9A67C-1E99-408C-923A-0275A916E2AFQ47144679-A8022C42-4809-4DC4-8749-970B0B7C88D7Q47273239-6DF19391-3DD2-452E-B01E-4FFAA7235BC6Q55228686-59F3B5AD-4AF4-470A-825B-2A31B8164179Q55265592-A7A02BB8-9394-40FB-9A4F-DB294FC66949Q55417295-4A63EC0C-D3C9-4E0C-9F68-2ABE1FB55D86
P2860
The ETS domain transcription factor ELK1 directs a critical component of growth signaling by the androgen receptor in prostate cancer cells
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
The ETS domain transcription f ...... eptor in prostate cancer cells
@ast
The ETS domain transcription f ...... eptor in prostate cancer cells
@en
type
label
The ETS domain transcription f ...... eptor in prostate cancer cells
@ast
The ETS domain transcription f ...... eptor in prostate cancer cells
@en
prefLabel
The ETS domain transcription f ...... eptor in prostate cancer cells
@ast
The ETS domain transcription f ...... eptor in prostate cancer cells
@en
P2093
P2860
P356
P1476
The ETS domain transcription f ...... eptor in prostate cancer cells
@en
P2093
Manohar Ratnam
Mesfin Gonit
Mugdha Patki
Robert Trumbly
Suneethi Sivakumaran
Venkatesh Chari
P2860
P304
11047-11065
P356
10.1074/JBC.M112.438473
P407
P577
2013-02-20T00:00:00Z